美国监管机构对三大最大的药房福利管理公司采取了法律行动，分别是CVS Health的Caremark、Cigna的Express Scripts和UnitedHealth的Optum Rx，指控这些药品中间商操纵胰岛素价格。这一消息是由《纽约时报》发布的。
Breaking News: U.S. regulators took legal action against the three largest pharmacy benefit managers — CVS Health’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx — accusing the drug middlemen of inflating insulin prices. https://t.co/c3QbyZx4i5
— The New York Times (@nytimes) September 20, 2024
阅读完整文章请点击这里：https://twitter.com/nytimes/status/1837165685719372276